Finasteride treatment may not prevent telogen effluvium after minoxidil withdrawal.
Tosti
Antonella
A
Iorizzo
Matilde
M
Vincenzi
Colombina
C
D000284:Administration, Oral; D000287:Administration, Topical; D000328:Adult; D000505:Alopecia / Q000188:drug therapy* / Q000209:etiology* / Q000473:pathology; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D018120:Finasteride / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008914:Minoxidil / Q000008:administration & dosage / Q000627:therapeutic use*; D013375:Substance Withdrawal Syndrome / Q000150:complications* / Q000473:pathology; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D004791:Enzyme Inhibitors; D014665:Vasodilator Agents; D018120:Finasteride; D008914:Minoxidil